Daniel J Kroon

Title: The Innovative Contributions of Daniel J Kroon

Introduction

Daniel J Kroon is a notable inventor based in Bridgewater, NJ (US), recognized for his significant contributions to the field of biomedical research. With a total of 8 patents, Kroon has made strides in developing methods and technologies that enhance the detection and treatment of infections and inflammations.

Latest Patents

Kroon's latest patents include groundbreaking work on labeled chemotactic peptides designed to image focal sites of infection. This invention relates to a method of detecting a site of infection or inflammation by administering a diagnostically or therapeutically effective amount of detectably labeled, therapeutic, or therapeutically-conjugated chemotactic peptide. This peptide accumulates substantially at the infected or inflamed site, providing a novel approach to treatment. Another significant patent involves immunoglobulin-binding polypeptides, which describe a method of separating V.sub.H containing immunoglobulins by admixing an immunoglobulin binding peptide. This polypeptide can bind to heavy chain variable regions of antibodies in an antigen-independent manner, facilitating the separation of antigen/antibody complexes.

Career Highlights

Throughout his career, Kroon has worked with esteemed organizations such as Ortho Pharmaceutical Corporation and the University of California. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in medical technology.

Collaborations

Kroon has collaborated with notable individuals, including Gideon Goldstein and George Heavner. These partnerships have further enriched his research and innovation efforts.

Conclusion

Daniel J Kroon's innovative work and patents have significantly impacted the biomedical field, particularly in the detection and treatment of infections. His contributions continue to pave the way for advancements in medical research and technology.